secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2023-12-11T23:59:59+00:00
Accession:  0001493152-23-044400
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa Therapeutics prices $5.0M public offering of common stock and warrants
------------------------------------------------------------------------------

- Offering of 4M shares (or pre-funded warrants in lieu) plus 4M Series A and 4M Series B warrants at combined $1.25 per unit.
- Gross proceeds ~$5.0M; net proceeds for working capital and general corporate purposes.
- Series A warrants $1.25 strike, 5-year term; Series B warrants $1.25 strike, 18-month term, both immediately exercisable.
- Offering closed on December 11, 2023; A.G.P./Alliance Global Partners acted as sole placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223044400/0001493152-23-044400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223044400/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-044400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer